<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infection</z:e> with the <z:hpo ids='HP_0012115'>hepatitis</z:hpo> E virus (HEV) causes a self-limiting <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, prolonged <z:e sem="disease" ids="C0042749" disease_type="Disease or Syndrome" abbrv="">viremia</z:e> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> has been reported in organ transplant recipients </plain></SENT>
<SENT sid="2" pm="."><plain>Vertically transmitted HEV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> is known to cause <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> in newborn babies </plain></SENT>
<SENT sid="3" pm="."><plain>The clinical course and duration of <z:e sem="disease" ids="C0042749" disease_type="Disease or Syndrome" abbrv="">viremia</z:e> in vertically transmitted HEV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in neonates in not known </plain></SENT>
<SENT sid="4" pm="."><plain>We studied 19 babies born to HEV infected mothers </plain></SENT>
<SENT sid="5" pm="."><plain>Babies were studied at birth and on a monthly basis to evaluate clinical profile, pattern of antibody response and duration of <z:e sem="disease" ids="C0042749" disease_type="Disease or Syndrome" abbrv="">viremia</z:e> in those infected with HEV </plain></SENT>
<SENT sid="6" pm="."><plain>Fifteen (78.9%) babies had evidence of vertically transmitted HEV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> at birth (IgM anti-HEV positive in 12 and HEV <z:chebi fb="40" ids="33697">RNA</z:chebi> reactive in 10) and three had short-lasting IgG anti-HEV positivity because of trans-placental antibody transmission </plain></SENT>
<SENT sid="7" pm="."><plain>Seven HEV-infected babies had icteric <z:hpo ids='HP_0012115'>hepatitis</z:hpo>, five had anicteric <z:hpo ids='HP_0012115'>hepatitis</z:hpo> and three had high serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> with <z:mpath ids='MPATH_458'>normal</z:mpath> liver enzymes </plain></SENT>
<SENT sid="8" pm="."><plain>Seven babies died in first week of birth (<z:e sem="disease" ids="C0728731" disease_type="Disease or Syndrome" abbrv="">prematurity</z:e> 1, icteric HEV 3, anicteric HEV 2 and <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> 1) </plain></SENT>
<SENT sid="9" pm="."><plain>Nine babies survived and were followed up for clinical, biochemical, serological course and duration of <z:e sem="disease" ids="C0042749" disease_type="Disease or Syndrome" abbrv="">viremia</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Five of 9 babies who survived were HEV <z:chebi fb="40" ids="33697">RNA</z:chebi> positive </plain></SENT>
<SENT sid="11" pm="."><plain>HEV <z:chebi fb="40" ids="33697">RNA</z:chebi> was not detectable by 4 weeks of birth in three babies, by 8 weeks in one and by 32 weeks in one </plain></SENT>
<SENT sid="12" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> surviving babies had self-limiting disease and none had prolonged <z:e sem="disease" ids="C0042749" disease_type="Disease or Syndrome" abbrv="">viremia</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>Thus HEV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> is commonly transmitted from mother-to-foetus and causes high neonatal mortality </plain></SENT>
<SENT sid="14" pm="."><plain>HEV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in survivors is self-limiting with short lasting <z:e sem="disease" ids="C0042749" disease_type="Disease or Syndrome" abbrv="">viremia</z:e> </plain></SENT>
</text></document>